Eli Lilly (LLY) is in advanced negotiations to acquire privately held biotech Kelonia Therapeutics in a deal valued at more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results